• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Quality

    Icosapent Ethyl Reduces Hospitalization And Death Risk

    GLOBENEWSWIRE

    FDA Action Alert: Merck and Amarin

    BIOSPACE

    Amarin Announces Proposed Settlement of its First Amendment Lawsuit Against FDA

    FDA LAW BLOG

    Latest FDLI Update Magazine Features Analysis of Amarin Case Written by HP&M Attorneys

    FDA

    Whither Off-Label Communications Policy?

    PHARMA EXECUTIVE

    Pacira sues FDA over pain drug marketing restrictions

    REUTERS

    FDA Tries to Blunt Amarin’s Free-Speech Lawsuit Over Off-Label Info

    PHARMALOT

    NCE Exclusivity Challenges are hot! Hot! HOT! Ferring Lets Loose with the Latest Lawsuit Challenging Denial of NCE Exclusivity for Colon Cleansing Drug

    FDA LAW BLOG

    All For One and One For All? NOPE! Court Rejects FDA’s “One-to-Many” Complex Mixture NCE Exclusivity Decision on VASCEPA; Remands to FDA For Further Proceedings

    FDA LAW BLOG

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.